John Mascarenhas, MD, associate professor, Icahn School of Medicine at Mount Sinai, discusses the role of <em>JAK2</em> inhibition in patients with polycythemia vera (PV).
John Mascarenhas, MD, associate professor, Icahn School of Medicine at Mount Sinai, discusses the role ofJAK2
Abbas Looks at the Use of Ruxolitinib and Fedratinib in Myelofibrosis
May 30th 2023In the second part of a live discussion on treating patients with myelofibrosis, Jonathan Abbas, MD, led a talk on the impact of ruxolitinib for these patients and where physicians stand with the use of fedratinib.
Read More
2 Clarke Drive
Cranbury, NJ 08512